Compounds > suberoyl bis-hydroxamic acid
Page last updated: 2024-11-04

suberoyl bis-hydroxamic acid and Carcinoma, Squamous Cell

suberoyl bis-hydroxamic acid has been researched along with Carcinoma, Squamous Cell in 1 studies

suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chikamatsu, K1
Ishii, H1
Murata, T1
Sakakura, K1
Shino, M1
Toyoda, M1
Takahashi, K1
Masuyama, K1

Other Studies

1 other study available for suberoyl bis-hydroxamic acid and Carcinoma, Squamous Cell

ArticleYear
Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck.
    Cancer science, 2013, Volume: 104, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Bindi

2013